Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Identification of a Selective RORγ Ligand That Suppresses T(H)17 Cells and Stimulates T Regulatory Cells.
Highlights from the 31st ECTRIMS congress - Barcelona 2015.
Interferon beta-1a for multiple sclerosis: old drug, new clothes.
[Applications of Optical Coherence Tomography (OCT) in Neuro-ophthalmology.]
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
Pediatric Multiple Sclerosis with Primary Progressive Course-Report of a Retrospective Cohort Study in Iran.
Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?
Multicenter measurements of myelin water fraction and geometric mean T2 : Intra- and intersite reproducibility.
Upper limb functional electrical stimulation devices and their man-machine interfaces.
Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Human Wharton?s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
The primate autoimmune encephalomyelitis model; a bridge between mouse and man.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
Role of Chlamydia in Multiple Sclerosis.
Participation of interleukin 17A in neuroimmune interactions.
Double Inversion Recovery Sequence of the Cervical Spinal Cord in Multiple Sclerosis and Related Inflammatory Diseases.
Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Pages
« first
‹ previous
…
324
325
326
327
328
329
330
331
332
…
next ›
last »